Sign In
Buy ERFSF
$70.54
-1.96 (-2.71%)
At Close: Jun 22, 2026
Eurofins Scientific SE: Director/PDMR Shareholding
06:29am, Monday, 30'th Jun 2025
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Deali
Eurofins Scientific: Director/PDMR Shareholding
06:02am, Wednesday, 25'th Jun 2025
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notificat
Eurofins Scientific SE: Director/PDMR Shareholding
11:12am, Tuesday, 17'th Jun 2025
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Deali
Eurofins Scientific SE: Director/PDMR Shareholding
07:49am, Friday, 13'th Jun 2025
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Deali
Eurofins Scientific SE: Director/PDMR Shareholding
11:00am, Tuesday, 10'th Jun 2025
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Deali
EUROFINS SCIENT (ERFSF) Upgraded to Strong Buy: Here's Why
01:06pm, Wednesday, 28'th May 2025
EUROFINS SCIENT (ERFSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Eurofins Scientific SE: Director/PDMR Shareholding
01:38pm, Monday, 26'th May 2025
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Deali
Eurofins Scientific SE: Director/PDMR Shareholding
08:30am, Monday, 19'th May 2025
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Deali
Eurofins Scientific: Anticipate Revenue Growth And Margin Expansion By 2027
10:30am, Thursday, 15'th May 2025
Eurofins Scientific delivered strong Q1 revenue growth and robust 2024 cash flow, supporting confidence in its 2025 and 2027 guidance. The company is executing well on organic growth and M&A, with a c
Eurofins Scientific: Director/PDMR Shareholding
09:00am, Friday, 09'th May 2025
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Deali
Eurofins Scientific SE (ERFSF) Q2 2025 Earnings Call Transcript
03:31pm, Wednesday, 23'rd Apr 2025
Eurofins Scientific SE (OTCPK:ERFSF) Q2 2025 Earnings Conference Call April 23, 2025 9:00 AM ET Company Participants Gilles Martin - Chairman and CEO Laurent Lebras - Group Administration and CFO Conf
Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year?
10:45am, Friday, 18'th Apr 2025
Here is how EUROFINS SCIENT (ERFSF) and Genelux Corporation (GNLX) have performed compared to their sector so far this year.
EUROFINS SCIENT (ERFSF) Upgraded to Buy: Here's What You Should Know
01:05pm, Wednesday, 02'nd Apr 2025
EUROFINS SCIENT (ERFSF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Has EUROFINS SCIENT (ERFSF) Outpaced Other Medical Stocks This Year?
10:40am, Wednesday, 02'nd Apr 2025
Here is how EUROFINS SCIENT (ERFSF) and Abbott (ABT) have performed compared to their sector so far this year.
Eurofins Scientific SE (ERFSF) Q4 2024 Earnings Call Transcript
03:19pm, Thursday, 30'th Jan 2025
Eurofins Scientific SE (OTCPK:ERFSF) Q4 2024 Earnings Call Transcript January 30, 2025 9:00 AM ET Company Participants Gilles Martin - Chairman of the Board & Chief Executive Officer Laurent Lebras -
